Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003441
What this trial is testing

Irofulven in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 26
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00911170
What this trial is testing

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Who this might be right for
CancerColon CancerColorectal Cancer+5 more
Amgen 847
Not applicableActive Not RecruitingNCT07448662
What this trial is testing

Local Treatment Strategies for Brain Metastases of Colorectal Cancer

Who this might be right for
Colorectal CancerBrain Metastases, Adult
Blokhin's Russian Cancer Research Center 700
Large-scale testing (Phase 3)Study completedNCT00905047
What this trial is testing

Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Centre Oscar Lambret 89
Testing effectiveness (Phase 2)Ended earlyNCT00107315
What this trial is testing

Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Roswell Park Cancer Institute 16
Testing effectiveness (Phase 2)Study completedNCT04426669
What this trial is testing

Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

Who this might be right for
Gastrointestinal Epithelial CancerGastrointestinal NeoplasmsCancer of Gastrointestinal Tract+8 more
Intima Bioscience, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT01037790
What this trial is testing

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Who this might be right for
Adult Solid TumorAdenocarcinoma of the ColonAdenocarcinoma of the Rectum+36 more
Abramson Cancer Center at Penn Medicine 304
Testing effectiveness (Phase 2)WithdrawnNCT01270438
What this trial is testing

Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01703910
What this trial is testing

Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic

Who this might be right for
Adenocarcinoma of ColonAdenocarcinoma of RectumMetastatic Disease
Centro Nacional de Investigaciones Oncologicas CARLOS III 29
Testing effectiveness (Phase 2)Looking for participantsNCT07629960
What this trial is testing

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Who this might be right for
Advanced Solid TumorNon-Small Cell Lung CancerColorectal Neoplasms+1 more
Blueprint Medicines Corporation 265
Early research (Phase 1)Study completedNCT02232152
What this trial is testing

CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+13 more
Wake Forest University Health Sciences 19
Post-approval studies (Phase 4)Study completedNCT00559676
What this trial is testing

Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Centre Hospital Regional Universitaire de Limoges 200
Not applicableStudy completedNCT00896896
What this trial is testing

Immunoreactivity to Cetuximab in Cancer Patients

Who this might be right for
Colorectal CancerHead and Neck Cancer
Vanderbilt-Ingram Cancer Center 538
Testing effectiveness (Phase 2)Study completedNCT00004870
What this trial is testing

Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
The University of Texas Health Science Center at San Antonio
Not applicableUnknownNCT06135571
What this trial is testing

Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer

Who this might be right for
Colorectal CancerLymph Node Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 3,000
Testing effectiveness (Phase 2)Ended earlyNCT00390364
What this trial is testing

Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy

Who this might be right for
Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT00006046
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Ludwig Institute for Cancer Research 7
Testing effectiveness (Phase 2)Study completedNCT00103311
What this trial is testing

SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IIIA Colon Cancer+9 more
National Cancer Institute (NCI) 64
Next Page